Showing 981 - 1,000 results of 133,719 for search '(( 5 ((((nn decrease) OR (point decrease))) OR (a decrease)) ) OR ( 2 c decrease ))', query time: 1.92s Refine Results
  1. 981

    Spatial stability is decreased in APP/PS1 mice in both dCA1 and vCA1. by Udaysankar Chockanathan (18510288)

    Published 2024
    “…<p>(A) In dCA1, stability score was significantly decreased in APP/PS1 mice relative to C57BL/6 mice (mean ± std: C57BL/6 = -0.009 ± 0.292, APP/PS1 = -0.1845 ± 0.256, p < 10<sup>−6</sup>, two-sided Wilcoxon rank-sum test, n<sub>C57BL/6</sub> = 295 units from 5 recording sessions, n<sub>APP/PS1</sub> = 167 units from 4 recording sessions). …”
  2. 982
  3. 983
  4. 984
  5. 985
  6. 986
  7. 987
  8. 988
  9. 989
  10. 990
  11. 991

    Decreased Serum Level of miR-146a as Sign of Chronic Inflammation in Type 2 Diabetic Patients by Lucy Baldeón R. (674016)

    Published 2014
    “…<div><p>Background</p><p>There is increasing evidence that chronic inflammation is an important determinant in insulin resistance and in the pathogenesis of type 2 diabetes (T2D). MicroRNAs constitute a newly discovered system of cell regulation and in particular two microRNAs (miR-146a and miR-155) have been described as regulators and biomarkers of inflammation.…”
  12. 992
  13. 993

    Decrease of invasive pneumococcal disease (IPD) in adults after introduction of pneumococcal 13-valent conjugate vaccine in Spain by Jordi Càmara (3910963)

    Published 2017
    “…IPD due to all PCV13 additional serotypes significantly declined with the exception of serotype 3 (-11.3%; 95%CI -35.0% to 21.1%). IPD due to two non-PCV13 serotypes varied: serotype 6C that rose (301.6%; 95%CI, 92.7% to 733.3%, p<0.001), related to the expansion of ST386<sup>6C</sup>, and serotype 8 that decreased (-34.9%, 95%CI, -57.1 to -1.2, p = 0.049), related to a decline of the ST63<sup>8</sup>. …”
  14. 994
  15. 995

    Regenerating axons are increased by ATRA and decreased by clodronate. by Valeria De La Rosa-Reyes (6658613)

    Published 2021
    “…(B) PBS treatment, composite from 2 sections (C) ATRA-treatment, single section (D) Clodronate liposome treatment, composite from 2 sections. …”
  16. 996
  17. 997
  18. 998
  19. 999
  20. 1000